These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16396493)

  • 1. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
    Hou T; McLaughlin W; Lu B; Chen K; Wang W
    J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling and prediction of binding affinities between the human amphiphysin SH3 domain and its peptide ligands using genetic algorithm-Gaussian processes.
    Zhou P; Tian F; Chen X; Shang Z
    Biopolymers; 2008; 90(6):792-802. PubMed ID: 18814309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
    Liang G; Chen G; Niu W; Li Z
    Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
    Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
    J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and predicting interactions between the human amphiphysin SH3 domains and their peptide ligands based on amino acid information.
    Cai J; Ou R; Xu YS; Yang L; Lin Z; Shu M
    J Pept Sci; 2010 Nov; 16(11):627-32. PubMed ID: 20853307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative structural and energetic analysis of WW domain-peptide interactions.
    Schleinkofer K; Wiedemann U; Otte L; Wang T; Krause G; Oschkinat H; Wade RC
    J Mol Biol; 2004 Nov; 344(3):865-81. PubMed ID: 15533451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
    Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
    Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
    Larson SM; Davidson AR
    Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
    Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
    J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
    Batra-Safferling R; Granzin J; Mödder S; Hoffmann S; Willbold D
    Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
    Kim J; Lee CD; Rath A; Davidson AR
    J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
    Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
    J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
    Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
    J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
    Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
    Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.